News - Inflammatory diseases, Glenmark Pharmaceuticals

Filter

Popular Filters

Glenmark gets $4 million milestone in Forest collaboration

Glenmark gets $4 million milestone in Forest collaboration

27-03-2014

Indian drugmaker Glenmark Pharmaceuticals has informed the Stock Exchange today that the company through…

FinancialForest LaboratoriesGlenmark PharmaceuticalsInflammatory diseasesLicensingPharmaceutical

Forest Labs and Glenmark collaborate; Takeda and Amylin cancel obesity accord

27-12-2012

Indian drugmaker Glenmark Pharmaceuticals has entered into an agreement with Forest Laboratories (NYSE:…

AmylinBiotechnologyBristol-Myers SquibbForest LaboratoriesGlenmark PharmaceuticalsInflammatory diseasesLicensingMetabolicsmetreleptinNeurologicalPharmaceuticalpramlintideResearchTakeda Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top